Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01413555 · ClinicalTrials.gov registry record · NA
Multicenter Blood Culture Quality Improvement
A NA study of Bacteremia, sponsored by Vanderbilt University.
- Completed
- Registry status
- NA
- Development phase
- 14,889
- Enrollment target
- 2
- Study locations
NCT01413555 is a NA study of Bacteremia that has completed, run by Vanderbilt University. The registered enrollment target is 14,889 participants, above the 6,223-participant average among 11 other Bacteremia trials with a reported enrollment target (139% higher). The trial reports 2 study locations across 1 state.
The verdict
NCT01413555, a NA study of Bacteremia, has completed, sponsored by Vanderbilt University.
- COMPLETED
- Registry status
- NA
- Development phase
- 14,889 participants
- Enrollment target
- 2
- Study locations
Study Summary
False positive blood culture results due to specimen contamination with bacteria inhabiting patients' skin is a common problem in emergency departments (EDs) in the United States. Contaminated blood cultures lead to patient harm through unnecessary hospitalizations and ED visits, delays in surgery, unneeded antibiotics, and unnecessary procedures. The investigators have developed a multifaceted quality improvement improvement bundle (The Blood Culture QI Program) designed to minimize blood culture contamination in the ED. In this study, the investigators will implement the quality improvement bundle in six community hospital EDs and evaluate its effectiveness at reducing contamination.
Conditions Studied
Interventions
- OTHER Blood Culture QI Program
Study Locations (2)
Tennessee
- Vanderbilt Emergency Medicine - Nashville
- Vanderbilt University Medical Center Emergency Medicine - Nashville
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 14,889 participants |
| Start Date | 2011-08 |
| Est. Completion | 2013-03 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01413555
The ClinicalTrials.gov registry entry for NCT01413555 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 14,889 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 6,223-participant average among 11 other Bacteremia trials with a reported enrollment target (139% higher). The listed sponsor is Vanderbilt University, which has 430 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Bacteremia appearing as the primary indexed condition, and to 1 intervention - of which Blood Culture QI Program is the first listed.
NCT01413555 reports 2 study locations spanning 1 distinct geographic area - top geographies include Tennessee.
Frequently Asked Questions
What is clinical trial NCT01413555 about?
NCT01413555 is a clinical study titled "Multicenter Blood Culture Quality Improvement". False positive blood culture results due to specimen contamination with bacteria inhabiting patients' skin is a common problem in emergency departments (EDs) in the United States. Contaminated blood cultures lead to patient harm through unnecessary hospitalizations and ED visits, delays in surgery, ...
What is the current status of trial NCT01413555?
This trial is currently completed. It is a NA study. The enrollment target is 14,889 participants. The study started on 2011-08. Estimated completion is 2013-03.
What conditions does trial NCT01413555 study?
This clinical trial studies the following conditions: Bacteremia.
What interventions are being tested in trial NCT01413555?
The interventions under investigation include: Blood Culture QI Program (OTHER).
Who is sponsoring clinical trial NCT01413555?
This trial is sponsored by Vanderbilt University, which has 430 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01413555 being conducted?
This trial has 2 study locations across Tennessee. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Bacteremia
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Reducing Risk for Infective Endocarditis
RECRUITING · NA
-
Bacteremia Antibiotic Length Actually Needed for Clinical Effectiveness
COMPLETED · NA
-
Evaluation of Emergency Medicine Pharmacist Impact on Blood Culture Review Following Emergency Department Discharge
RECRUITING
-
Monocyte Distribution Width (MDW) in the General Population of Emergency Department Patients With and Without Bacteremia
ACTIVE NOT RECRUITING
-
Antibiotic Administration and Blood Culture Positivity in Severe Sepsis and Septic Shock
COMPLETED
-
Comparison of Infection Rates Among Patients Using Two Catheter Access Devices
COMPLETED
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.